Same Indication

Nivolumab vs Ondansetron

Nivolumab vs Ondansetron: Overview

This comparison examines the pharmacological differences between Nivolumab and Ondansetron.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Ondansetron: Selective 5-HT3 receptor antagonist.

Pharmacokinetics

Half-life: Nivolumab — 27 days; Ondansetron — 3-5 hours.

Chemical Properties

Molecular Formula: Ondansetron — C18H19N3O.

Molecular Weight: Ondansetron — 293.3660 g/mol.

Type: Nivolumab — Antibody; Ondansetron — Small molecule.